Is the combination of orphenadrine and paracetamol safe for lactating women, and is hyoscine N‑butylbromide (hyoscine NBB) safe for breastfeeding?

Safety of Orphenadrine + Paracetamol and Hyoscine NBB in Lactating Women

Paracetamol is safe during breastfeeding, but orphenadrine should be avoided due to lack of safety data in lactation; hyoscine N-butylbromide (NBB) is generally considered safe for breastfeeding women due to its poor oral bioavailability and quaternary ammonium structure.

Paracetamol (Acetaminophen)

Paracetamol is explicitly safe for lactating women 1. The amount transferred into breast milk is significantly less than pediatric therapeutic doses, despite wide variation in milk concentrations 1. This makes it a first-line analgesic choice during breastfeeding.

Orphenadrine - Major Concern

Orphenadrine lacks adequate safety data for lactation. The FDA label provides no information about breast milk excretion or infant safety 2. Key concerns include:

• No established safety profile during breastfeeding
• The drug label explicitly states "Safety of continuous long-term therapy with orphenadrine has not been established" 2
• No data on milk transfer or infant effects
• Orphenadrine is an anticholinergic muscle relaxant that could theoretically cause infant sedation, poor feeding, or anticholinergic effects

Clinical recommendation: Avoid orphenadrine during lactation. Consider safer alternatives like ibuprofen (extensively studied and safe 1) or morphine for short-term use if stronger analgesia is needed 1.

Hyoscine N-Butylbromide (Hyoscine NBB)

Hyoscine NBB is likely safe during breastfeeding based on its pharmacological properties:

• Quaternary ammonium compound with poor lipid solubility 1
• Ionized at physiological pH, resulting in minimal breast milk transfer 1
• Poor oral bioavailability (38% for similar compounds like phenylephrine 1), meaning even if small amounts reach milk, infant absorption would be negligible
• Used for abdominal cramping and has been studied in combination with paracetamol for dysmenorrhea 3

The guideline on breastfeeding medications notes that quaternary ammonium compounds (like glycopyrronium) are "probably preferred" over tertiary amines due to poor bioavailability 1. While hyoscine NBB isn't specifically mentioned in the guidelines, its chemical structure places it in this safer category.

Practical Algorithm

For pain/spasm management in lactating women:

1. First-line: Paracetamol alone (safe, well-studied)
2. If antispasmodic needed: Hyoscine NBB can be added (likely safe based on pharmacology)
3. Avoid: Orphenadrine + paracetamol combination (insufficient safety data)
4. Alternative for muscle pain: Ibuprofen (extensively studied, safe 1)

Important Caveats

• Monitor the infant for any unusual drowsiness, poor feeding, or behavioral changes when using any medication during breastfeeding
• Use lowest effective doses for the shortest duration 1
• The combination product (orphenadrine + paracetamol) should be avoided specifically because of the orphenadrine component, not the paracetamol
• If stronger analgesia is required, morphine is the preferred opioid with established safety data 1

The evidence strongly supports paracetamol use and suggests hyoscine NBB is acceptable, but the lack of data on orphenadrine makes it an inappropriate choice for lactating women when safer alternatives exist.